Table 1. Diagnostics criteria for the metabolic syndrome by four definitions.

Components	NCEP-ATP III (Third Report of the NCEP, 2002)	AHA/NHLBI (Grundy et al. 2005)	IDF (Zimmet et al. 2005)	JIS (Alberti et al. 2009)
Fasting plasma glucose	≥6.1 mmol/L	≥5.6 mmol/L or T2DM	≥5.6 mmol/L or T2DM	≥5.6 mmol/L or T2DM
Waist circumference	≥102 cm (men)	≥102 cm (men)	≥94 cm (men)	≥94 cm (men)
	≥88 cm (women)	≥88cm (women)	≥80 cm (women)	≥80 cm (women)
Blood pressure	≥130/85 mm Hg	≥130/85 mm Hg or receiving treatment	≥130/85 mm Hg or receiving treatment	≥130/85 mm Hg or receiving treatment
Triglycerides	≥1.7 mmol/L	≥1.7 mmol/L or receiving treatment	≥1.7 mmol/L or receiving treatment	≥1.7 mmol/L or receiving treatment
High-density lipoprotein cholesterol	<1.0 mmol/L (men) <1.3 mmol/L (women)	<1.0 mmol/L (men) <1.3 mmol/L (women) or receiving treatment	<1.0 mmol/L (men) <1.3 mmol/L (women) or receiving treatment	<1.0 mmol/L (men) <1.3 mmol/L (women) or receiving treatment
Definition of metabolic syndrome and number of components for diagnosis	≥3 of the components above	≥3 of the components above	Central obesity (increased waist circumference) plus ≥2 others components	≥3 of the components above

AHA/NHLBI American Heart Association and National Heart Lung and Blood Institute,

IDF International Diabetes Federation,

JIS Joint Interim Societies,

NCEP-ATPIII National Cholesterol Education Program Adult Treatment Panel III,

T2DM type 2 diabetes mellitus